J. Silvio Gutkind, PhD – UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in Metastatic Uveal Melanoma AACR https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-announces-presentation-preclinical-data-0

You May Also Be Interested In:

VS-6766 + Defactinib in Non-Small Cell Lung Cancer